Search research articles
Contact Us
Filters
Showing results (11-20 of 79) with videos related to
Page
of 8
Sort By:
Science (New York, N.Y.)
|
November 1, 1974
Evidence for in vivo reaction of antibody and complement to surface antigens of human cancer cells
K Irie, R F Irie, D L Morton
Cancer Research
|
December 15, 1996
Development of a human monoclonal antibody to ganglioside G(M2) with potential for cancer treatment
Y Nishinaka, M H Ravindranath, R F Irie
Journal of the National Cancer Institute
|
January 1, 1987
Gangliosides of human melanoma: GM2 and tumorigenicity
T Tsuchida, R E Saxton, R F Irie
Cellular Immunology
|
February 1, 1988
Gangliosides from human melanoma immunomodulate response of T cells to interleukin-2
D S Hoon, R F Irie, A J Cochran
Journal of Autoimmunity
|
December 1, 1994
Attachment of monophosphoryl lipid A (MPL) to cells and liposomes augments antibody response to membrane-bound gangliosides
M H Ravindranath, D L Morton, R F Irie
Proceedings of the National Academy of Sciences of the United States of America
|
September 1, 1982
Human antibody to OFA-I, a tumor antigen, produced in vitro by Epstein-Barr virus-transformed human B-lymphoid cell lines
R F Irie, L L Sze, R E Saxton
The Journal of Biological Chemistry
|
February 5, 1988
Human melanoma antigen O-acetylated ganglioside GD3 is recognized by Cancer antennarius lectin
M H Ravindranaths, J C Paulson, R F Irie
Seminars in Surgical Oncology
|
January 1, 1989
Human monoclonal antibodies: prospects for the therapy of cancer
J H Wong, R F Irie, D L Morton
Journal of the National Cancer Institute
|
September 1, 1981
Oncofetal antigen-I: distribution in human tumors
W V Rees, R F Irie, D L Morton
Journal of the National Cancer Institute
|
August 1, 1979
Oncofetal antigen: a tumor-associated fetal antigen immunogenic in man
R F Irie, A E Giuliano, D L Morton
Page
of 8
Search research articles
Search
Showing results (11-20 of 79) with videos related to
Sort By:
Page
of 8
Science (New York, N.Y.)
|
November 1, 1974
Evidence for in vivo reaction of antibody and complement to surface antigens of human cancer cells
K Irie, R F Irie, D L Morton
Cancer Research
|
December 15, 1996
Development of a human monoclonal antibody to ganglioside G(M2) with potential for cancer treatment
Y Nishinaka, M H Ravindranath, R F Irie
Journal of the National Cancer Institute
|
January 1, 1987
Gangliosides of human melanoma: GM2 and tumorigenicity
T Tsuchida, R E Saxton, R F Irie
Cellular Immunology
|
February 1, 1988
Gangliosides from human melanoma immunomodulate response of T cells to interleukin-2
D S Hoon, R F Irie, A J Cochran
Journal of Autoimmunity
|
December 1, 1994
Attachment of monophosphoryl lipid A (MPL) to cells and liposomes augments antibody response to membrane-bound gangliosides
M H Ravindranath, D L Morton, R F Irie
Proceedings of the National Academy of Sciences of the United States of America
|
September 1, 1982
Human antibody to OFA-I, a tumor antigen, produced in vitro by Epstein-Barr virus-transformed human B-lymphoid cell lines
R F Irie, L L Sze, R E Saxton
The Journal of Biological Chemistry
|
February 5, 1988
Human melanoma antigen O-acetylated ganglioside GD3 is recognized by Cancer antennarius lectin
M H Ravindranaths, J C Paulson, R F Irie
Seminars in Surgical Oncology
|
January 1, 1989
Human monoclonal antibodies: prospects for the therapy of cancer
J H Wong, R F Irie, D L Morton
Journal of the National Cancer Institute
|
September 1, 1981
Oncofetal antigen-I: distribution in human tumors
W V Rees, R F Irie, D L Morton
Journal of the National Cancer Institute
|
August 1, 1979
Oncofetal antigen: a tumor-associated fetal antigen immunogenic in man
R F Irie, A E Giuliano, D L Morton
Page
of 8